Setmelanotide is a selective MC4R agonist that reached regulatory approval for specific rare genetic obesity indications, and it is the appropriate comparator if MC4R is your question
B., Zoricic, I., Gjurasin, M., Stupnisek, M., Romic, Z., Zarkovic, K.,
I highly recommend this
These multi-agent compounds are used in chronic wound management, post-surgical care, and pressure injury treatment where commercial wound care products offer insufficient therapeutic breadth
B., Pavic, P., Mestrovic, T., Sjekavica, I.,
The Melanocortin Mechanism PT-141 is a brain-based approach to treating both female hypoactive sexual disorder and, increasingly, male sexual dysfunctions